Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol NRXN1 contributors: mct - updated : 06-04-2016
HGNC name neurexin 1
HGNC id 8008
Corresponding disease
IDEM intellectual disability, epilepsy, macrocephaly
PTHS2 Pitt-Hopkins 2
Location 2p16.3      Physical location : 50.145.643 - 51.259.674
Synonym name
  • neurexin I-alpha
  • neurexin I-beta
  • Synonym symbol(s) RN1AH, KIAA0578, NX1A, FLJ35941, Hs.22998, DKFZp313P2036, PTHSL2, SCZD17
    DNA
    TYPE functioning gene
    STRUCTURE 1114.03 kb     22 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    text structure
  • CCG repeat in 5'utr
  • two promoters: one promoter for the transcription of alpha neurexin and one for beta
  • MAPPING cloned Y linked N status tentative : very preliminary evidence
    RNA
    TRANSCRIPTS type messenger
    text
  • with long and shorter both with alternatively spliced isoforms (PMID: 9448462)
  • activity-dependent alternative splicing requires the KH-domain RNA-binding protein KHDRBS1 that associates with RNA response elements in the NRXN1 pre-mRNA (PMID: 21620750)
  • identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    24 - 9578 - 1547 heart, brain 1994 8163501
    22 - 9368 - 1477 - 1994 8163501
    lacks the N terminal five LNS domains and the EGF-like repeats, the C terminus region is conserved
    6 - 5593 - 442 - -
    EXPRESSION
    Type widely
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Cardiovascularheart     Homo sapiensAdultNM_001135659
    Hearing/Equilibriumearinnercochlea highly
    Nervousbrain   highly Homo sapiensAdultNM_001135659
     nerve   highly
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • a N terminal signal peptide
  • three overall repeats, each composed of two similar domains LNS (laminin A/neurexin/sex hormone-binding globulin) separated from each other by an EGF-like sequence
  • an O-glycosylation site and a single TM segment
  • a short cytoplasmic tail
  • HOMOLOGY
    interspecies homolog to rattus neurexin I alpha
    intraspecies homolog to NRXN3
    Homologene
    FAMILY
  • neurexin family
  • CATEGORY adhesion , signaling , receptor
    SUBCELLULAR LOCALIZATION     plasma membrane
    basic FUNCTION
  • neuronal cell surface protein that may be involved in cell recognition and cell adhesion by forming intracellular junctions through binding to neuroligins
  • plays an important role in synaptic development
  • have a fundamental role in synaptogenesis and synaptic maintenance
  • having an important role in synaptic function
  • polymorphic presynaptic protein implicated in synaptic plasticity and memory processing
  • CELLULAR PROCESS cell communication
    PHYSIOLOGICAL PROCESS nervous system
    text axon guidance
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • binding the potent excitatory neurotoxin alpha-latrotoxin
  • interacting with neuroligin
  • SORCS1 localizes to early and recycling endosomes and regulates neurexin and AMPAR surface trafficking
  • selective binding between NRXN1 and LRRTM1/LRRTM2 modulated by the S4 insertion of NRXN1
  • SORCS1 is a critical regulator of trafficking of neuronal receptors, including the presynaptic adhesion molecule neurexin (NRXN1), an essential synaptic organizer
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) PTHS2 , IDEM
    Susceptibility
  • to autism spectrum disorder, see AUTS19
  • to schizophrenia
  • to nicotine dependence (ND)
  • to autism spectrum disorder, developmental delay, and speech delay
  • Variant & Polymorphism other
  • mutation increasing the risk of nicotine dependence,
  • disrupted by rare CNVs in schizophrenia patients
  • duplicated in patients with autism spectrum disorder, developmental delay, and speech delay
  • Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS